Neuphoria Therapeutics Inc. Liquidation Value

NEUP Other

Cash & Equivalents

$22.17M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $22.17M
Total Obligations: -$2.59M
$19.58M
Per share: $3.64
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $22.17M
AR: $1.11M
Total Obligations: -$2.59M
$20.69M
Per share: $3.85
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $22.17M
AR: $1.11M
Inventory: $0
Total Obligations: -$2.59M
$20.69M
Per share: $3.85
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$19.58M$3.64
Liquid Liquidation Value$20.69M$3.85
Operating Liquidation Value$20.69M$3.85

Key Components (as of 2025-12-31)

Cash & Equivalents$22.17M
Accounts Receivable$1.11M
InventoryN/A
Current Liabilities$2.59M
Long-term DebtN/A
Op. Lease Liability$0
Finance LeaseN/A
Shares Outstanding5.4M

Explore all 98 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$22.17M$1.11MN/A$520,709$2.59MN/A$0N/A
2025-09-30$13.65M$1,758N/A$1.37M$5.12MN/A$85,210N/A
2025-06-30$14.21M$11,948N/A$1.15M$4.22MN/A$116,314N/A
2025-03-31$17.04M$24,592N/A$745,336$1.55MN/A$141,060N/A
2024-12-31$4.34M$35,561N/A$1.53M$2.13MN/A$168,310N/A
2024-09-30$8.08M$115,960N/A$1.33M$2.55MN/A$219,350N/A
2024-06-30$12.61M$126,884N/A$2.24M$3.83MN/A$239,618N/A
2024-03-31$8.43MN/AN/AN/AN/AN/AN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-Q 2026-02-17 View
2025-09-30 10-Q 2025-11-14 View
2025-06-30 10-K 2025-09-29 View
2025-03-31 10-Q 2025-05-20 View
2024-12-31 10-Q 2025-02-14 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-K 2024-09-30 View

Community Notes

Loading notes...

Questions

Loading questions...